- Report
- October 2024
- 187 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- July 2024
- 159 Pages
Global
From €5649EUR$5,950USD£4,765GBP
- Report
- February 2025
- 193 Pages
Global
From €5174EUR$5,450USD£4,364GBP
- Report
- March 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- August 2024
- 146 Pages
Global
From €2847EUR$2,999USD£2,402GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1899EUR$2,000USD£1,602GBP
- Report
- February 2025
- 180 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- September 2024
- 163 Pages
Latin America
From €2373EUR$2,500USD£2,002GBP
- Report
- March 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- July 2024
- 100 Pages
Global
From €3560EUR$3,750USD£3,003GBP
- Report
- July 2024
- 48 Pages
Global
From €3793EUR$3,995USD£3,199GBP
- Report
- November 2024
- 150 Pages
Global
From €5649EUR$5,950USD£4,765GBP
- Report
- March 2025
- 898 Pages
Global
From €5316EUR$5,600USD£4,484GBP
- Report
- March 2025
- 578 Pages
Global
From €5174EUR$5,450USD£4,364GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- November 2024
- 140 Pages
Global
From €5649EUR$5,950USD£4,765GBP
- Report
- February 2025
- 134 Pages
Global
From €2847EUR$2,999USD£2,402GBP
- Report
- July 2024
- 172 Pages
Global
From €2373EUR$2,500USD£2,002GBP
- Report
- April 2024
- 185 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- August 2024
- 18 Pages
Global
From €14235EUR$14,995USD£12,008GBP

The Migraine Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Migraine drugs are used to treat the symptoms of migraine headaches, such as nausea, vomiting, and sensitivity to light and sound. These drugs can be divided into two categories: abortive and preventive. Abortive drugs are taken at the onset of a migraine attack to reduce the severity of symptoms, while preventive drugs are taken on a regular basis to reduce the frequency of migraine attacks. Common abortive drugs include triptans, ergot alkaloids, and non-steroidal anti-inflammatory drugs (NSAIDs). Common preventive drugs include beta-blockers, anticonvulsants, and serotonin receptor agonists.
Some companies in the Migraine Drug market include GlaxoSmithKline, Pfizer, Novartis, Merck, and Allergan. Show Less Read more